COVID-19 and Burkholderia cepacia co-infection in pregnancy associated with fetal demise: a case report

Pan Afr Med J. 2022 Jul 4:42:173. doi: 10.11604/pamj.2022.42.173.33813. eCollection 2022.

Abstract

Since the global pandemic of the 2019 coronavirus disease (COVID-19), few studies have reported on the relevance of bacteria co-infection on outcome of COVID-19 patients. Little is known about the clinical presentation among pregnant women, mother-to-child transmission, and fetal outcomes. This report shows a 24-year-old nulliparous woman who was 32 weeks pregnant and was admitted to the University Hospital, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi Ghana with symptoms of fever (40.3°C), cough and breathlessness of two weeks duration. Her nasopharyngeal sample tested positive for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and blood culture isolated Burkholderia cepacia. She was given medications but went into pre-term labour and delivered a stillborn baby. This rare case of COVID-19 and Burkholderia cepacia co-infection emphasizes the need for a thorough assessment and appropriate treatment of patients presenting with fever and respiratory symptoms in order to mitigate poor outcome.

Keywords: Burkholderia cepacia; COVID-19; SARS-CoV-2; case report; pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Burkholderia cepacia*
  • COVID-19* / complications
  • COVID-19* / diagnosis
  • Coinfection* / diagnosis
  • Female
  • Fetal Death
  • Fever / etiology
  • Humans
  • Infectious Disease Transmission, Vertical
  • Pregnancy
  • Pregnancy Complications, Infectious* / diagnosis
  • Pregnancy Outcome
  • SARS-CoV-2
  • Young Adult